Home > Blog Tag

Blog Posts by Tag: COVID-19

The Impact of COVID-19 on Remote Patient Monitoring, Medical Device, and IDTF Patient Engagement Tools

This blog post is part two of a three part series. View Part One. According to the “COVID 19 Telehealth Impact Study,” conducted by the COVID 19 Healthcare Coalition, 75% of physicians reported they would like to continue to offer digital services for chronic disease management post-COVID. These findings confirm that physicians see the value in providing digital and telehealth services as a part...

Read


How COVID-19 Influenced Billing and Patient Access Tools for Telehealth, Remote Patient Monitoring, Medical Device, and IDTF

Recently, I had the pleasure of participating in a Fierce Healthcare webinar, “Billing and Patient Access Tools to Boost Digital Health Profits.” During the webinar, I addressed how COVID-19 changed billing and patient access tools for remote patient monitoring (RPM), medical device, and independent device testing facilities (IDTFs). My presentation covered three main topics: COVID impacts to...

Read


You Invested to Meet the Demand for COVID-19 Testing: How Do You Optimize that Investment Post-Pandemic?

At the beginning of the COVID-19 pandemic in the U.S., many laboratories invested in equipment, supplies, and personnel to manage the surge of COVID-19 test demand. For the laboratory information system (LIS), the backbone of the laboratory IT infrastructure, this meant new workflows, report templates, and instrument interfaces to handle the new COVID-19 Polymerase Chain Reaction (PCR) tests.Once...

Read


Lab Week 2021: Reflection and Gratitude

Once again, Lab week is upon us. As the second year celebrating Medical Laboratory Professionals Week (MLPW) in the midst of a global pandemic, it’s worth taking a moment to celebrate all our lab professionals and pathologists. Diagnostics is such a vital piece of the healthcare puzzle, and frontline laboratorians have been visible in unprecedented ways throughout the pandemic, but it is still...

Read


Preparing for Market Disruption – Operational Lessons From COVID-19

Conor WardVP of Sales, XIFIN Joe NollarAVP LIS Product Development, XIFIN In March 2021, we had the privilege of being interviewed by Linda Wilson, Senior Editor of Medical Laboratory Observer (MLO). The discussion focused on what has been learned by laboratories during the COVID-19 pandemic so far...

Read


After Large Spikes in 2020, Diagnostic Laboratory Testing Volumes on the Decline

As XIFIN CEO Lâle White wrote in her recent LinkedIn article, the COVID-19 pandemic created many challenges for the diagnostic industry in 2020. In the preceding years, many laboratories were running lean with little excess capacity. With the surge in COVID-19 testing demand, labs had to quickly add capacity to handle the new testing volume. In addition, dynamic regulatory changes designed to...

Read


Payor Relations Insider: The Introduction of Turnaround Time Requirements for SARS–CoV–2 Testing

To ensure COVID testing is performed in as timely a manner as possible, CMS created a turnaround time-dependent reimbursement policy. Since its introduction in January 2021, many other payors have also adopted this pricing schema. The COVID-19 Public Health Emergency has created new burdens for clinical diagnostic laboratories. The results of these SARS-CoV-2 tests are used for critical treatment...

Read


HRSA High Throughput COVID-19 Claims: Correction Timeline

HHS confirmed there was a system error in the reimbursement for high throughput COVID-19 PCR testing claims, with HCPCS U0003 and U0004, for the HRSA COVID-19 Uninsured Patient Program. HHS indicated on their FAQ page they would not implement the add-on reimbursement for HCPCS U0005 on January 1, 2021 and would continue reimbursing independent laboratories at the rate of $100 for COVID-19 PCR...

Read